Article
Down syndrome and leukemia: insights into leukemogenesis and translational targets.
1 Apr 2015
Abstract excerpt
Children with Down syndrome (DS) have a significantly increased risk of childhood leukemia, in particular acute megakaryoblastic leukemia (AMKL) and acute lymphoblastic leukemia (DS-ALL). A pre-leukemia, called transient myeloproliferative disorder (TMD), characterised by a GATA binding protein 1 (GATA1) mutation, affects up to 30% of newborns with DS. In most cases, the pre-leukemia regresses spontaneously,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
